Literature DB >> 2823686

The role of vitamin D3 in the proliferation of a human colon cancer cell line in vitro.

P Lointier1, M J Wargovich, S Saez, B Levin, D M Wildrick, B M Boman.   

Abstract

LoVo, a cultured colon cancer cell line, is shown to possess a receptor for 1,25-dihydroxy vitamin D3 (1 alpha,25(OH)2D3) with a low capacity (28 fmol/mg protein) and high affinity (Kd: 1.9 x 10(-21)0M). When these cells were grown in monolayer culture in a chemically defined serum-free medium, a significant inhibition of proliferation was seen in the presence of 10 nM to 1 microM of 1 alpha,25(OH)2D3 (p less than 0.005. Furthermore, 1 alpha,25(OH)2D3 delayed early attachment of cells. After 8 days of treatment, aggregated cuboidal cells showed a marked change to an apparently spindle like morphology. The 1 alpha,25(OH)2D3 growth-inhibitory effect was modulated by verapamil (1 microM), a calcium channel blocker, hydrocortisone (1 microM), and moxestrol (1 mM), an estrogen analogue, and 2% charcoal-treated fetal bovine serum. This study represents the first demonstration of 1 alpha,25(OH)2D3 modulation of growth of human colon cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2823686

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  20 in total

1.  Update of preclinical and human studies of calcium and colon cancer prevention.

Authors:  Martin Lipkin
Journal:  World J Gastroenterol       Date:  1999-12       Impact factor: 5.742

Review 2.  Vitamin D and cancer: a review of molecular mechanisms.

Authors:  James C Fleet; Marsha DeSmet; Robert Johnson; Yan Li
Journal:  Biochem J       Date:  2012-01-01       Impact factor: 3.857

3.  Slug expression inhibits calcitriol-mediated sensitivity to radiation in colorectal cancer.

Authors:  Victoria J Findlay; R Eric Moretz; Cindy Wang; Silvia G Vaena; Savannah G Bandurraga; Michael Ashenafi; David T Marshall; Dennis K Watson; E Ramsay Camp
Journal:  Mol Carcinog       Date:  2013-08-31       Impact factor: 4.784

4.  Low bone mineral density linked to colorectal adenomas: a cross-sectional study of a racially diverse population.

Authors:  Shilpa Gowda; Seth Lipka; Ashley H Davis-Yadley; Huafeng Shen; Jeffrey Silpe; Andy White; Sam Satler; Dustin Luebbers; James Statler; Anna Zheng; Joshua Elder; Albin Abraham; Prakash Viswanathan; Paul Mustacchia
Journal:  J Gastrointest Oncol       Date:  2015-04

5.  Emerging role of vitamin D in colorectal cancer.

Authors:  Wonmo Kang; Sujin Lee; Eunyi Jeon; Ye-Rang Yun; Kook-Hyun Kim; Jun-Hyeog Jang
Journal:  World J Gastrointest Oncol       Date:  2011-08-15

6.  Cholecalciferol or 25-hydroxycholecalciferol neither prevents nor treats adenomas in a rat model of familial colon cancer.

Authors:  Amy A Irving; Lori A Plum; William J Blaser; Madeline R Ford; Chao Weng; Linda Clipson; Hector F DeLuca; William F Dove
Journal:  J Nutr       Date:  2014-12-24       Impact factor: 4.798

7.  The influence of health and lifestyle characteristics on the relation of serum 25-hydroxyvitamin D with risk of colorectal and breast cancer in postmenopausal women.

Authors:  Marian L Neuhouser; JoAnn E Manson; Amy Millen; Mary Pettinger; Karen Margolis; Elizabeth T Jacobs; James M Shikany; Mara Vitolins; Lucile Adams-Campbell; Simin Liu; Erin LeBlanc; Karen C Johnson; Jean Wactawski-Wende
Journal:  Am J Epidemiol       Date:  2012-02-22       Impact factor: 4.897

Review 8.  Vitamin D deficiency in early life and the potential programming of cardiovascular disease in adulthood.

Authors:  Oksan Gezmish; Mary Jane Black
Journal:  J Cardiovasc Transl Res       Date:  2013-05-30       Impact factor: 4.132

9.  Vitamin D and its metabolites inhibit cell proliferation in human rectal mucosa and a colon cancer cell line.

Authors:  M G Thomas; S Tebbutt; R C Williamson
Journal:  Gut       Date:  1992-12       Impact factor: 23.059

10.  Colorectal cancer and solar radiation.

Authors:  J C Emerson; N S Weiss
Journal:  Cancer Causes Control       Date:  1992-01       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.